Skip to content

Auditory Verbal Hallucinations in Borderline Personality Disorder and the Efficacy of Antipsychotics: A Systematic Review.

Christina W. Slotema, Jan Dirk Blom, Marieke B A Niemantsverdriet, Iris E C Sommer

Frontiers in Psychiatry 2018 DOI: 10.3389/fpsyt.2018.00347 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Sample size 1,263
Population Patients with borderline personality disorder across 36 studies
Interventions cognitive-behavioral therapy non-invasive brain stimulation
Topics Philosophy of mind
Keywords Childhood trauma Comorbidity Prevalence Psychotic symptoms
Key findings AVH occur in roughly a quarter of BPD patients (25% overall, 24% of outpatients, 27% of hospitalized patients) and are linked to more suicide plans and attempts, more frequent hospitalization, and higher rates of PTSD and emotional abuse. The authors conclude that typical and atypical antipsychotics tend to have positive effects on AVH in BPD, while the efficacy of cognitive-behavioral therapy and non-invasive brain stimulation has not been systematically assessed.

Abstract

Background: Auditory verbal hallucinations (AVH) are experienced more frequently by patients with borderline personality disorder (BPD) than previously assumed. However, consensus is lacking on how to treat them.

Objective: To provide a systematic review of studies reporting on AVH in patients with BPD, with a focus on the efficacy of treatment of psychotic symptoms.

Methods: For this review a systematic search was made in the PubMed and Ovid databases, and mean weighted prevalence rates, adjusted for sample size, were computed.

Results: The search yielded 36 studies describing a total of 1,263 patients. Auditory hallucinations (including AVH) were reported in 27% of hospitalized BPD patients; AVH were reported in 25% of all patients and in 24% of outpatients. Of the hallucinating patients, 78% experienced AVH at least once per day, for a duration of several days to many years. On the whole, patients with BPD regarded their voices as malevolent and omnipotent in nature. Compared to patients with schizophrenia, the phenomenological characteristics of AVH were similar and the ensuing distress was equal or even higher, whereas scores for other positive symptoms were lower. The presence of AVH in BPD was associated with an increase of suicide plans and attempts, and more frequent hospitalization. Moreover, AVH in the context of BPD were associated with higher prevalence rates for post-traumatic stress disorder and emotional abuse. The efficacy of antipsychotics was investigated in 21 studies. Based on these studies, we conclude that both typical and atypical antipsychotics tend to have positive effects on AVH experienced in the context of BPD. The efficacy of cognitive-behavioral therapy and non-invasive brain stimulation has not yet been systematically assessed.

Conclusions: These findings indicate that AVH experienced in the context of BPD are in need of proper diagnosis and treatment, and that antipsychotics tend to be beneficial in treating these (and other psychotic) symptoms.There is an urgent need for studies assessing the efficacy of cognitive-behavioral therapy and non-invasive brain stimulation in this underdiagnosed and undertreated group.

Comparable studies

Other systematic reviews and meta-analyses on philosophy of mind, most cited first.

Study Year Design Participants
The brain in flow: A systematic review on the neural basis of the flow state. Participants in studies measuring or manipulating flow state with brain activity recording 2022 Systematic review n = 471
Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology. 2024 Systematic review and meta-analysis
Evidence synthesis indicates contentless experiences in meditation are neither truly contentless nor identical Expert texts from Shamatha, Transcendental, and Stillness Meditation traditions 2022 Systematic review n = 135
Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients: Potential changes in the phenomenology of psychiatric diseases Patients with severe mental illness (SMI), such as psychotic patients 2017 Systematic review
Scoping review on shamanistic trances practices. 2024 Systematic review

Citations in the library

Explore topics